YEAR 2 SYSTEMS REVIEW - PSYCHIATRY + INTEGRATED TRANSFER

YEAR 2 | PAGE 50D - SYNDROME / DURATION / FUNCTION -> SAFETY / EXCLUSIONS -> DIAGNOSIS / PHARM + 10 CROSS-DOMAIN CASES

PSYCH SPINE: MSE / SYNDROME -> DURATION + FUNCTIONAL IMPAIRMENT -> SUBSTANCE / MEDICATION / MEDICAL EXCLUSIONS -> SAFETY -> DIAGNOSIS -> THERAPY / ADVERSE EFFECT. NEURO + PSYCH OVERLAP WHEN COGNITION, MOVEMENT, TOXICITY OR ALTERED MENTAL STATUS BLURS THE BOUNDARY. J. PSYCHIATRY REVIEW MAP + TOP 10 #9 TO #10

LANE	MUST RETRIEVE WITHOUT NOTES	HIGH-DISCRIMINATION TRANSFER
Mood / bipolar	Depression vs grief/adjustment; mania/hypomania; psychotic features; suicidality and functional impairment.	Use duration + impairment + episode relationship before choosing treatment.
Psychosis / delirium	Schizophrenia-spectrum vs mood with psychosis vs substance/medical; delirium and neurocognitive disorders.	Attention/fluctuation, time course and medical/substance context can outweigh a psychotic symptom itself.
Anxiety / trauma / sleep	Panic/GAD/OCD/PTSD, somatic symptoms, insomnia and sleep disorders.	Distinguish syndrome duration, trigger/avoidance pattern and safety before medication recall.
Substance / personality / child	Intoxication/withdrawal, personality patterns, developmental/child psychiatry.	Use pattern over time, context and functional consequences rather than one behavior.
Psychopharmacology	Antidepressants, antipsychotics, lithium/mood stabilizers, anxiolytics; EPS/metabolic effects, serotonin syndrome, NMS and withdrawal.	Mechanism + signature toxicity + monitoring is more transferable than memorizing isolated drug lists.

PSYCH SPINE: MSE / SYNDROME -> DURATION + FUNCTIONAL IMPAIRMENT -> SUBSTANCE / MEDICATION / MEDICAL EXCLUSIONS -> SAFETY -> DIAGNOSIS -> THERAPY / ADVERSE EFFECT. NEURO + PSYCH OVERLAP WHEN COGNITION, MOVEMENT, TOXICITY OR ALTERED MENTAL STATUS BLURS THE BOUNDARY. J. PSYCHIATRY REVIEW MAP + TOP 10 #9 TO #10

# / CONCEPT	DEEP EXPLANATION	WHY STUDENTS MISS IT	EASIEST CLUE
9. Psychiatric diagnosis is timeline + function + exclusions	Symptoms become a diagnosis only when duration, clustering, impairment and exclusions fit. Medical illness, substances and medications can mimic primary psychiatric disease.	Students recognize a symptom word such as “depressed” or “psychotic” and jump to the closest label.	Write syndrome + duration + impairment + exclusions before naming the diagnosis.
10. Medication toxicity can mimic the disease you are	Serotonin syndrome, NMS, lithium toxicity, withdrawal, EPS and metabolic effects can present with psychiatric or neurologic	Drug adverse effects are memorized separately from diagnosis, so they are not considered when	New neuro/autonomic symptoms after a drug change = consider
treating	symptoms. Mechanism and time course help separate toxicity from relapse.	symptoms change after treatment.	toxicity before assuming relapse.

K. SUBSTANTIVE DIRECT VIDEOS - PSYCHIATRY / NEUROPHARM

RESOURCE	ROLE IN THIS REVIEW
Ninja Nerd - Drugs for Epilepsy HyGuru - Top NBME Concepts: Psychiatry	Mechanism-first antiseizure pharmacology, selection and toxicity. Long-form active-recall mood, psychosis, eating and substance-use review.
Ninja Nerd - Anxiolytic & Hypnotic Drugs Dirty Medicine - Dopamine Pathways, Antipsychotics + EPS	Anxiety/insomnia pharmacology with major safety and adverse effects. Dopamine pathways linked to antipsychotic effects, EPS and endocrine adverse effects.
UWorld Step 1 NBME CBSSA	Primary mixed vignette transfer after system mechanisms are stable. External-style formative calibration interpreted with school guidance and multiple readiness signals.

L. 10 HIGH-DISCRIMINATION CROSS-DOMAIN CASES

#	CASE	ANSWER LOGIC
1	Acute hot swollen knee + fever.	Do not anchor on gout: classify as acute monoarthritis and exclude infection with synovial analysis when clinically appropriate.
2	Symmetric small-joint morning stiffness + anti-CCP.	Inflammatory phenotype comes first; anti-CCP strengthens RA probability rather than creating the diagnosis by itself.
3	Young adult with malar/photosensitive pattern, cytopenias and renal findings.	Multisystem immune-complex phenotype + serology/complement context supports SLE reasoning; organ involvement drives urgency.
4	New painful rash with mucosal erosions after a medication.	Danger-first dermatology: mucosal/systemic involvement after a drug raises severe cutaneous-adverse-reaction concern before exact image labeling.
5	Pigmented lesion changing in asymmetry/border/color.	Describe morphology/evolution, recognize malignancy concern, and use biopsy/pathology rather than visual certainty alone.
6	Aphasia + contralateral face/arm weakness.	Localize to dominant cerebral hemisphere/MCA-type territory before naming stroke; predict associated cortical signs.
7 8	Ipsilateral cranial-nerve finding + contralateral body weakness. Fluctuating weakness improves with use? vs worsens with use?	Crossed findings strongly suggest a brainstem localization; crossing logic is the discriminator. Use reflexes, sensation, autonomics and fatigability to separate NMJ patterns such as MG vs Lambert-Eaton from neuropathy/myopathy.
9	Psychosis with fluctuating attention and acute medical illness.	Delirium/medical cause must be considered before primary psychotic disorder; attention and fluctuation are high-value clues.
10	Antipsychotic exposure + rigidity, fever and autonomic instability.	Medication emergency pattern: mechanism/time course favor NMS-type toxicity over simple psychiatric relapse.

L. 10 HIGH-DISCRIMINATION CROSS-DOMAIN CASES — M. FOUR-DOMAIN MASTERY GATE

Ready to move to the Year 2 integrated 7-link chain when you can: (1) classify MSK complaints and interpret synovial fluid, antibodies and imaging in context; (2) describe unfamiliar skin lesions by morphology/distribution and identify danger patterns; (3) localize neurologic lesions by level, side, tract/territory and tempo before disease naming; (4) distinguish psychiatric syndromes using duration, function, exclusions and safety; and (5) connect major therapies to mechanism and signature toxicity. School-specific objectives and supervised clinical/OMM skills remain authoritative for performance assessment. 2026/27 systems-review expanded edition - align with school objectives and verify official exam updates before testing